Sponsor Pipeline

Aspeya, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-22 NCT07646613
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine…		 Trial sites expanded: 3 -> 6 locations
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07646613 Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine… Migraine Recruiting
Phase 1
NCT07665892 Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma Safety in Asthma Patients Recruiting
Disease Areas
Migraine (1) Asthma (1)
Get alerts when Aspeya, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free